Aberdeen University outlicenses synthetic bone technologies

Licensing

Aberdeen University, Scotland, has signed a multiple licensing agreement with ApaTech, an orthobiologics specialist, for three new technologies in the field of synthetic bone.  

ApaTech will focus its efforts to refine and commercialise these early-stage technologies into products for use in orthopaedic, spinal and dental surgical procedures to repair and regenerate damaged bone.  

The technologies focus on three key opportunities for improving synthetic bone grafting materials by the incorporation of biologically active silicon and other ionic species into orthopaedic graft materials to enhance bone repair; enabling the improved MRI imaging of synthetic bone graft materials following surgical implantation to facilitate monitoring during healing; and increasing understanding of how biomaterials can enhance bone regeneration.

ApaTech is the developer and manufacturer of Actifuse, a synthetic silicate substituted calcium phosphate bone graft material for orthopaedic, spinal, dental and craniomaxillofacial applications.  The Actifuse scaffold mimics the body’s natural bony structure and accelerates the growth of high quality bone.

Tom Buckland, Vice President of Research & Development for ApaTech, said, “ApaTech’s relationships with leading academic centres are the key to finding the new technologies in the field of orthobiologics, which will push the boundaries of what medicine can deliver.